Company Information
CIN
Status
Date of Incorporation
16 January 2002
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
50,000,000
Authorised Capital
50,000,000
Directors
Riyan Ahmed Khan
Director/Designated Partner
about 2 years ago
about 2 years ago
Morten Bryde Hansen
Director
over 2 years ago
over 2 years ago
Prem Kumar Yogeshappa
Director/Designated Partner
over 3 years ago
over 3 years ago
Past Directors
Maninder Singh Sawhney
Additional Director
almost 7 years ago
almost 7 years ago
Jacob Oommen
Director
about 9 years ago
about 9 years ago
Rune Ejler Moesgaard Andersen
Additional Director
over 9 years ago
over 9 years ago
Mammen Mathew
Director
about 10 years ago
about 10 years ago
Herman Santoni Ramos
Director
about 11 years ago
about 11 years ago
Ole Chrintz
Director
about 14 years ago
about 14 years ago
Registered Trademarks
[Class : 5] Pharmaceutical Preparations Used For The Prevention, Management And Treatment Of Headaches, Migraines, Pain, Immune And Inflammatory Disorders And Diseases, And Neurological Disorders And Conditions.
[Class : 5] Pharmaceutical Preparations Used For The Prevention, Management And Treatment Of Headaches, Migraines, Pain, Immune And Inflammatory Disorders And Diseases, And Neurological Disorders And Conditions.
[Class : 5] Pharmaceutical Preparations Used For The Prevention, Management And Treatment Of Headaches, Migraines, Pain, Immune And Inflammatory Disorders And Diseases, And Neurological Disorders And Conditions.
View +43 more Brands for Lundbeck India Private Limited.
Documents
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30122020
Form AOC-4(XBRL)-30122020
Form ADT-3-16122020_signed
Form ADT-1-15122020_signed
Copy of written consent given by auditor-15122020
Copy of the intimation sent by company-15122020
Copy of resolution passed by the company-15122020
Resignation letter-14122020
Form MGT-14-06112020_signed
Form MGT-7-06112020_signed
Optional Attachment-(1)-04112020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-04112020
List of share holders, debenture holders;-04112020
Form DPT-3-05102020-signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-19092020
Optional Attachment-(1)-19092020
Form DIR-12-19092020_signed
Form MSME FORM I-10092020_signed
Form AOC-4(XBRL)-30102019_signed
Optional Attachment-(1)-27102019
List of share holders, debenture holders;-27102019
Form MGT-7-27102019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-26102019
Form MGT-14-25102019_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-25102019
Optional Attachment-(1)-25102019
Form DIR-12-14022019_signed
Notice of resignation;-14022019
Evidence of cessation;-14022019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-14022019
